Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.

Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.4.2 was added to the record history. The funding status notice and the earlier revision (v3.4.1) were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a site-wide Notice about government funding lapse and potential data delays. Updated the history with Revision: v3.4.1 and removed v3.4.0.SummaryDifference0.9%

- Check28 days agoChange DetectedThe history page now includes a glossary toggle, clarifies color-coded changes with additions shown in green and deletions in red, and introduces a new revision tag v3.4.0, while the earlier No FEAR Act data entry and the v3.3.4 revision note were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check64 days agoChange DetectedThe page history shows a new revision label 'Revision: v3.3.3' was added, and the footer items 'HHS Vulnerability Disclosure' and the older 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history now lists a new release entry: Revision: v3.3.2, replacing Revision: v3.3.1 in the study's version history. This is an administrative update to release notes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision history shows a new entry for v3.3.1 added and v3.2.0 removed, reflecting a minor UI/versioning update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.